版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversityLectureTwoMicrobiology中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversitymacrophagecytokineepidemicconjugationchromosome中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity
colony
phageproteaseplaceboallergy中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversitybeingsmallestinsizeaffectingneworganismsviruseshavetoinvadebodycellformultiplicationbeingunabletosurviveoutsidethehostforlong中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversitydon’tcauseanydiseasedigestionyouhaveweakimmunitymostlysimpleandcomplaintssubsidebythemselvesareonlyeffectiveagainstbacterialinfectionwashingyourhands,coveringyourmouthwithtissuepaperorclothwheneveryoucoughorsneezetakingpropercareoflittlewoundsbydisinfectingthemVaccine中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversityprogenychromosomes,genomesself-transmissiblehorizontal中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversitycomplementaryextracellularCompetencygeneticrecombination中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity
Vocabularyspore[sp??(r)]孢子germinate[?d???m?ne?t]萌芽,開(kāi)始生長(zhǎng)incubator[???kjube?t?(r)](細(xì)菌)培養(yǎng)箱allergic[??l??d??k]過(guò)敏的species[?spi??i?z]種genus[?d?i?n?s]屬rash[r??]皮疹中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity1.WhatdidFlemingfindwhenhereturnedtothelabaftervacation?HefoundaPetridishwascontaminatedbyacolonyofmoldandnobacteriagrewinthezonesurroundingthiscolonyofmold.Fleminghypothesizedthatthemoldwassecretingsomekindofcompoundthatcouldkillthebacteria.PenicilliumcolonyStaphylococciundergoinglysisNormalStaphylococcalcolony中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity2.Howdoespenicillindestroybacteria?Penicillindisruptsthesynthesisofthecellwallandpreventsitfrombeingreconstructedatacriticalphase.Meanwhile,penicillinstimulatesthe
releaseofhighlyreactivemolecules
thatcauseadditionaldamage.Thetwomechanismsworktogethertomakethecell’sstructurebreak
downcompletely.中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversityBecausemethodsfortheisolationandmassiveproductionofpenicillinhadn’tbeensuccessfullydeveloped.3.WhydidpenicillinremainalaboratorycuriositymanyyearsafterFleming’sdiscovery?4.Whydomanypeoplehavethemisperceptionthattheyareallergictopenicillin?Manypatientsmistakenlyattributethedevelopmentofrashafterpenicillintreatmenttoallergy.Actually,themorelikelyculpritistheoriginalinfection,orareactionbetweentheinfectionandtheantibiotic.Genuinepenicillinallergiesrarelyoccur.中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity
Vocabularyemergencyuseauthorization緊急使用授權(quán)(atoolthattheFDAcanusetomakeaproductavailableduringapandemicwithoutfullevidenceofsafetyandeffectiveness)Paxlovid帕克洛維nirmatrelvir奈瑪特韋ritonavir利托那韋remdesivir瑞德西韋hospitaladmission[?h?sp?tl?d?m??n]入院、住院tolerate[?t?l?re?t](對(duì)藥物)耐受antiarrhythmic[‘,?nt??’r?em?k]抗心律失常藥antipsychotic[?nt?sa?k?t?k]抗精神病藥中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity1.ForthepurposeofdealingwithCOVID-19,whatdoyouthinkaretheadvantagesoforaldrugsovervaccines?EasyandconvenientstorageandtransportationSelf-administeredandpain-free
Thesimplest,mostconvenient,andsafestmeansofdrugadministration
Providetreatmentoptionwhenvaccinesfailtopreventtheinfection中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity2.DoyouknowotherdrugcombinationsthatcanproducesynergisticeffectasinthecaseofPaxlovid?PaxlovidNirmatrelvir:apotentproteaseinhibitortargetingaproteasethatcutsproteinsneededbySARS-CoV-2forviralreplicationRitonavir:apotentinhibitorofP450thatisinvolvedinthemetabolismofnirmatrelvir中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversityAssignment:searchforthesynergisticmechanismoflevodopaandcarbidopacombinationforthetreatmentofParkinson'sdiseaseLevodopaisaprodrugofdopamine;Levodopaisabletocrosstheblood-brainbarrierandthenmetabolisedbydecarboxylasetodopamine;Carbidopaisadecarboxylaseinhibitorlikethatpreventslevodopametabolismuntilafterithascrossedtheblood-brainbarrier.中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity3.WhatarethemajorclinicalbenefitsofPaxlovidaccordingtotheinterimdataofphase2andphase3studies?PatientswhotookPaxlovidwithinthreedaysofCOVIDsymptomshadan89%lowerriskofhospitaladmissionordeathwhencomparedtoaplacebogroup;Patientstreatedwithinfivedaysofsymptomonsethadsimilarreductionsintheriskofhospitaladmissionordeath;SimilarratesofadverseeventswerereportedforPaxlovid
andplacebogroups,indicatingthatthetreatmentwaswelltolerated;PatientswhoreceivedPaxlovidhadasignificantlylowerrateofseriousadverseevents.中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity
Vocabularyedge(微弱的)優(yōu)勢(shì)staphylococcusaureus[?st?f?l??k?k?s][???r??s]金黃色葡萄球菌MRSA(methicillin-resistantstaphylococcusaureus)耐甲氧西林金黃色葡萄球菌salmonella[s?lm?nel?]沙門(mén)氏菌
E.coli[?i??k??la?]大腸桿菌pneumonia[nju??m??ni?]肺炎
sepsis[?seps?s]膿毒癥β-lactamantibiotics[?l?kt?m]β-內(nèi)酰胺類(lèi)抗生素oxacillin[??ks??s?l?n]苯唑西林
quinolone[?kw?n??l??n]喹諾酮類(lèi)抗生素中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversityTrueorFalse1.Therearemoremicrobialcellsinaperson'sbodythanhumancells.2.Mostofthehugenumberofbacterialcellsinsideyoucancauseharmfulinfections.3.Allantibioticsareproducedfromnaturalsourceslikemold.4.Antibioticscankillorinhibitthegrowthofbacteria,andtheyarealsoharmfultohumancells.5.Someantibioticsstopworkingbecausetherearesomeproblemswiththeseantibioticsthemselves.6.Abacteriumoftenundergoesmutationsandmanyofthese
mutationsaremeaningful,forexample,makingitresistanttoacertainantibiotic.7.Reproductionistheonlywaytopasstheresistantgene.中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity1.Howdobacteriabecomeresistantandhowdotheypasstheresistantgenes?----vertical(reproduction)----horizontal(DNAreleasedbydeadbacteriaispickedupbyanotherbacterium,conjugation/connectingthroughpilitosharethegenes)----mutations;----killingofnon-resistancebacteriainantibiotic-richenvironmentleavesmoreroomandresourcesfortheresistantonesCauses:Transferofresistantgenes:中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity2.Accordingtothevideoclip,whatarethemechanismsthatbacteriausetobecomesuperbugs?BacteriaMechanismofresistanceMRSASalmonellaE.coliagenethatreplacestheprotein(that)beta-lactamsnormallytargetandbindtokeepsthecellwallsynthesisunaffectedproduceenzymeslikebeta-lactamasethatbreakdownantibioticattackersbeforetheycandoanydamagepreventtheentryofsomeantibioticslikequinolonesbyactivelybootinganyinvaders中國(guó)藥科大學(xué)ChinaPharmaceuticalUniversity3.Whatmeasureshavebeentakentocurbthedevelopmentofresistance?ThedevelopmentofnoveltreatmentsisprioritizedbyWHO;Alternativesolutionssuchasphagetherapyorusingvacc
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 園區(qū)報(bào)關(guān)201310教學(xué)內(nèi)容
- 5 我們的校園 (說(shuō)課稿)-部編版道德與法治 一年級(jí)上冊(cè)
- 二零二五版酒吧業(yè)態(tài)創(chuàng)新項(xiàng)目承包經(jīng)營(yíng)合同3篇
- 小區(qū)消防設(shè)施設(shè)備更新?lián)Q代項(xiàng)目2025年度合同2篇
- 2020-2025年中國(guó)環(huán)丙氟哌酸市場(chǎng)供需格局及投資規(guī)劃研究報(bào)告
- 精準(zhǔn)配送2025版鋼材運(yùn)輸合同模板2篇
- 2025年中國(guó)粉紅葡萄酒行業(yè)市場(chǎng)深度分析及發(fā)展前景預(yù)測(cè)報(bào)告
- 2019-2025年中國(guó)醫(yī)藥金屬包裝行業(yè)市場(chǎng)調(diào)查研究及投資前景預(yù)測(cè)報(bào)告
- 二零二五年度現(xiàn)代化碼頭使用權(quán)轉(zhuǎn)讓合同4篇
- 2024年魯西骨科醫(yī)院高層次衛(wèi)技人才招聘筆試歷年參考題庫(kù)頻考點(diǎn)附帶答案
- C及C++程序設(shè)計(jì)課件
- 帶狀皰疹護(hù)理查房
- 公路路基路面現(xiàn)場(chǎng)測(cè)試隨機(jī)選點(diǎn)記錄
- 平衡計(jì)分卡-化戰(zhàn)略為行動(dòng)
- 國(guó)家自然科學(xué)基金(NSFC)申請(qǐng)書(shū)樣本
- 幼兒教師干預(yù)幼兒同伴沖突的行為研究 論文
- 湖南省省級(jí)溫室氣體排放清單土地利用變化和林業(yè)部分
- 材料設(shè)備驗(yàn)收管理流程圖
- 培訓(xùn)機(jī)構(gòu)消防安全承諾書(shū)范文(通用5篇)
- (完整版)建筑業(yè)10項(xiàng)新技術(shù)(2017年最新版)
- 第8期監(jiān)理月報(bào)(江蘇版)
評(píng)論
0/150
提交評(píng)論